Prediagnostic use of hormone therapy and mortality after breast cancer (Q37428023)

20 August 2017

Prediagnostic use of hormone therapy and mortality after breast cancer (English)

1 reference

20 August 2017

1 reference

7

Meir J Stampfer

1 reference

20 August 2017

1

Polly A Newcomb

1 reference

20 August 2017

8

Walter C Willett

1 reference

20 August 2017

4

Linda Titus-Ernstoff

1 reference

20 August 2017

3

Amy Trentham-Dietz

1 reference

20 August 2017

Kathleen M Egan

2

1 reference

20 August 2017

John A Baron

series ordinal

5

1 reference

20 August 2017

John M Hampton

series ordinal

6

1 reference

20 August 2017

language of work or name

1 reference

1 April 2008

1 reference

Cancer Epidemiology, Biomarkers & Prevention

20 August 2017

1 reference

20 August 2017

17

1 reference

20 August 2017

4

1 reference

20 August 2017

864-871

1 reference

Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Postmenopausal estrogen and progestin use in relation to breast cancer risk

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Traditional and newer pathologic factors.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Postmenopausal hormone therapy and mortality.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Evidence of a healthy estrogen user survivor effect

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Decreased mortality in users of estrogen replacement therapy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Use of postmenopausal hormone therapy since the Women's Health Initiative findings

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Breast cancer survival and hormone replacement therapy: a cohort analysis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Reduced mortality associated with long-term postmenopausal estrogen therapy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Prognostic characteristics in breast cancers after hormone replacement therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780320

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

3 December 2018

1 reference

12 December 2020

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy

1 reference

12 December 2020

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

1 reference

12 December 2020

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

12 December 2020

Lactation in relation to postmenopausal breast cancer

1 reference

12 December 2020

Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy

1 reference

12 December 2020

Hormone replacement therapy for breast cancer survivors: an answered question?

1 reference

12 December 2020

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

1 reference

12 December 2020

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality

1 reference

12 December 2020

The impact of hormone replacement therapy on the detection and stage of breast cancer

1 reference

12 December 2020

Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use

1 reference

12 December 2020

Exogenous estrogens and development of breast and endometrial cancer

1 reference

12 December 2020

The relationship between breast cancer survival and prior postmenopausal estrogen use

1 reference

12 December 2020

Carcinoma of the breast in postmenopausal hormone user and nonuser control groups

1 reference

12 December 2020

10.1158/1055-9965.EPI-07-0610

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

1 reference